{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:37:56Z","timestamp":1762659476065,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2013R1A1A2013441"],"award-info":[{"award-number":["NRF-2013R1A1A2013441"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI14C0072","HI14C3418"],"award-info":[{"award-number":["HI14C0072","HI14C3418"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.tranon.2016.01.007","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T21:18:30Z","timestamp":1462051110000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing"],"prefix":"10.1016","volume":"9","author":[{"given":"Kwai Han","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayoung K.D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Il","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiryeon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungmi","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyojin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soomin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kee-Taek","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woong-Yang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Seok","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Oh","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.tranon.2016.01.007_bb0005","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"de Groen","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tranon.2016.01.007_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.tranon.2016.01.007_bb0015","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ijc.28161","article-title":"Biliary tract cancer incidence in the United States\u2014demographic and temporal variations by anatomic site","volume":"133","author":"Castro","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2016.01.007_bb0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820801992542","article-title":"Surgery for cholangiocarcinoma: the role of liver transplantation","volume":"10","author":"Rosen","year":"2008","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.tranon.2016.01.007_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2004-828895","article-title":"Surgical management of cholangiocarcinoma","volume":"24","author":"Jarnagin","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"16","key":"10.1016\/j.tranon.2016.01.007_bb0030","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2014.59.7591","article-title":"Biliary tract cancers: understudied and poorly understood","volume":"33","author":"Chan","year":"2015","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.tranon.2016.01.007_bb0035","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.tranon.2016.01.007_bb0040","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tranon.2016.01.007_bb0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","article-title":"Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer","volume":"7","author":"Glimelius","year":"1996","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.tranon.2016.01.007_bb0050","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.tranon.2016.01.007_bb0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11864-015-0366-0","article-title":"Targeted therapy in biliary tract cancers","volume":"16","author":"Merla","year":"2015","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"10.1016\/j.tranon.2016.01.007_bb0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24145","article-title":"Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities","volume":"53","author":"Zhu","year":"2011","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.tranon.2016.01.007_bb0065","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","article-title":"Genetics of biliary tract cancers and emerging targeted therapies","volume":"28","author":"Hezel","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.tranon.2016.01.007_bb0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MOG.0b013e32830bf7e1","article-title":"Endoscopic tissue diagnosis of cholangiocarcinoma","volume":"24","author":"Harewood","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"issue":"20","key":"10.1016\/j.tranon.2016.01.007_bb0075","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1200\/JCO.2005.19.729","article-title":"Endoscopic techniques to diagnose and manage biliary tumors","volume":"23","author":"Brugge","year":"2005","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.tranon.2016.01.007_bb0080","doi-asserted-by":"crossref","first-page":"25619","DOI":"10.18632\/oncotarget.4627","article-title":"Patient-derived cell models as preclinical tools for genome-directed targeted therapy","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.tranon.2016.01.007_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibtech.2013.03.006","article-title":"Technologies for deriving primary tumor cells for use in personalized cancer therapy","volume":"31","author":"Mitra","year":"2013","journal-title":"Trends Biotechnol"},{"issue":"29","key":"10.1016\/j.tranon.2016.01.007_bb0090","doi-asserted-by":"crossref","first-page":"28211","DOI":"10.18632\/oncotarget.4721","article-title":"Gastrointestinal malignancies harbor actionable MET exon 14 deletions","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"32","key":"10.1016\/j.tranon.2016.01.007_bb0095","doi-asserted-by":"crossref","first-page":"33358","DOI":"10.18632\/oncotarget.5188","article-title":"The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"issue":"27","key":"10.1016\/j.tranon.2016.01.007_bb0100","doi-asserted-by":"crossref","first-page":"24320","DOI":"10.18632\/oncotarget.4462","article-title":"Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.tranon.2016.01.007_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111693","article-title":"High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.tranon.2016.01.007_bb0110","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.3748\/wjg.v21.i14.4121","article-title":"Optimum chemotherapy for the management of advanced biliary tract cancer","volume":"21","author":"Ghosn","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.tranon.2016.01.007_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(11)70301-1","article-title":"Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.tranon.2016.01.007_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejca.2011.11.017","article-title":"A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study","volume":"48","author":"Yi","year":"2012","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2016.01.007_bb0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","article-title":"Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial","volume":"15","author":"Malka","year":"2014","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.tranon.2016.01.007_bb0130","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/j.ejca.2014.09.013","article-title":"Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme","volume":"50","author":"Moehler","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.tranon.2016.01.007_bb0135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gut.52.5.706","article-title":"Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma","volume":"52","author":"Tannapfel","year":"2003","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.tranon.2016.01.007_bb0140","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1158\/1078-0432.CCR-05-1692","article-title":"Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma","volume":"12","author":"Leone","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.tranon.2016.01.007_bb0145","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.tranon.2016.01.007_bb0150","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.tranon.2016.01.007_bb0155","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke-associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.tranon.2016.01.007_bb0160","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.26890","article-title":"Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatology"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523315300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523315300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:31:41Z","timestamp":1761834701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523315300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1936523315300401"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2016.01.007","relation":{},"ISSN":["1936-5233"],"issn-type":[{"type":"print","value":"1936-5233"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2016.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}